23andMe (ME) - 2024 Q3 - Earnings Call Transcript

23andMe Holding Co. (NASDAQ:ME) Q3 2024 Earnings Conference Call February 7, 2024 4:30 PM ET Company Participants Ian Cooney - Senior Director of Investor Relations Anne Wojcicki - Co-Founder and Chief Executive Officer Joseph Selsavage - Interim Chief Financial and Accounting Officer Jennifer Low - Head of Therapeutics Development Bill Richards - Head of Therapeutics Discovery Conference Call Participants Steven Mah - TD Cowen Operator Hello, and welcome to 23andMe's Fiscal Year 2024 Third Quarter Financia ...